We are live on ! Find out more
ONTXW

Onconova Therapeutics, Inc. Warrants
ONTXW

Delisted

ONTXW was delisted on the 23rd of July, 2021.

Back to rankings

5 hedge funds and large institutions have $1.5M invested in Onconova Therapeutics, Inc. Warrants in 2018 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

9,873% more capital invested

Capital invested by funds: $15K → $1.5M (+$1.48M)

25% more funds holding

Funds holding: 4 → 5 (+1)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
5
Holders Change
+1
Holders Change %
+25%
% of All Funds
0.11%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
1
Increased
1
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
6CM
683 Capital Management
New York
+$148K
2
SM
Sabby Management
Florida
+$1.83K

Top Sellers

Rank Fund Capital Flow
1
CH
CVI Holdings
Delaware
-$498
2
UBS Group
UBS Group
Switzerland
-$180

ONTXW Hedge Fund Activity: Q3 2018 in Review

5 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in Onconova Therapeutics, Inc. Warrants (ONTXW) for Q3 2018, worth a combined $1.5M — up 9,873% from $15K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new ONTXW positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 2 trimmed.

The largest buyer was 683 Capital Management, opening a new position worth an estimated $148K. The largest seller was CVI Holdings, cutting an estimated $498.

  • 5 institutional investors held Onconova Therapeutics, Inc. Warrants (ONTXW) as of Q3 2018, up from 4 in Q2 2018.
  • Funds reported $1.5M of Onconova Therapeutics, Inc. Warrants stock for Q3 2018, up 9,873% quarter-over-quarter.
  • 1 fund opened new Onconova Therapeutics, Inc. Warrants positions in Q3 2018 and 0 closed out, a net change of +1 holder.
  • The largest Onconova Therapeutics, Inc. Warrants buyer in Q3 2018 was 683 Capital Management, an estimated $148K added.
  • The largest Onconova Therapeutics, Inc. Warrants seller in Q3 2018 was CVI Holdings, an estimated $498 sold.

Based on aggregated 13F filings for Q3 2018.